GeneDx (NASDAQ:WGS – Get Free Report) had its price objective upped by research analysts at Canaccord Genuity Group from $75.00 to $90.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s price target would indicate a potential upside of [...]
Canaccord Genuity Group Boosts GeneDx (NASDAQ:WGS) Price Target to $90.00
